Post Profile






Bayer, J&J win third U.S. trial over Xarelto bleeding risk

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding.
read more

share

Related Posts


J&J wins fourth trial in talc product liability lawsuits

Health : Reuters: Health

(Reuters) - Johnson & Johnson said on Friday that a state court jury in Missouri had returned a verdict in its favor in the fourth trial to arise out of thousands of lawsuits alleging the company's talc-based products can increase t...

J&J and Bayer's Xarel to cuts recurrence of dangerous blood clots in study

Health : Reuters: Health

WASHINGTON (Reuters) - Longer-term use of the oral blood thinner Xarelto significantly cut the risk of recurrence of potentially life-threatening blood clots with no additional major bleeding compared with low-dose aspirin in patien...

J&J, Bayer accused of hiding Xarelto's dangers, face 18,000 patient lawsuits

Health : Chicago Tribune: Health

Joseph Boudreaux says taking Johnson & Johnson's blood-thinning drug Xarelto was one of the biggest mistakes of his life. While Xarelto was supposed to help cut his stroke risk, Boudreaux says it instead caused internal bleeding tha...

Bayer, J&J win first product liability trial over Xarelto

Health : Reuters: Health

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on the blood thinner Xarelto, the drugmakers said on Wednesday.

Bayer, J&J win second U.S. trial over Xarelto bleeding risks

Health : Reuters: Health

(Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the second trial to stem from thousands of lawsuits blaming injuries on the blood thinner Xarelto, the drug companies said on Monday.

Comments


Copyright © 2016 Regator, LLC